Use of tri-substituted glycerol compounds for the treatment of radiation injuries

Details for Australian Patent Application No. 2007316589 (hide)

Owner Alphaptose GmbH

Inventors Richter, Wolfgang; Weber, Lutz

Agent Spruson & Ferguson

Pub. Number AU-A-2007316589

PCT Pub. Number WO2008/055997

Priority 60/858,170 10.11.06 US

Filing date 9 November 2007

Wipo publication date 15 May 2008

International Classifications

C07F 9/10 (1970.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/055997 Priority application(s): WO2008/055997

12 January 2012 Alteration of Name

  The name of the applicant has been altered to RadioProtect Alphaptose UG (haftungsbeschrankt) & Co. KG 2008

19 April 2012 Assignment before Grant

  RadioProtect Alphaptose UG (haftungsbeschrankt) & Co. KG The application has been assigned to RadioProtect Alphatose UG (haftungsbeschraenkt) & Co. KG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007316596-Device for the sealed coupling of two cylindrical pipes having different diameters

2007316588-Oral dosage form comprising trisubstituted glycerol compounds